Modalities

Modalities

RJX is Pioneering New Multimodal Technologies for Drug Development

Utilizing Technological Advances to Create Medical Solutions

Reven’s scientific research team has an ongoing commitment to compile and review RJX patient and study data to grow in our understanding of RJX. As an important part of this process, the team has spent countless hours scouring scientific literature to understand the pathology that RJX is positioned to influence. To organize this effort, Reven researchers have categorized candidate modalities as they relate to multiple disease states to further inform development of future dosing strategies, signals of interest, clinical plans, and future opportunities for variants built on the platform. A working list of diseases of interest are listed in alphabetical order and grouped by modality below.

Modalities

Electrolyte Balance

  • Chronic Yeast Infection
  • CKD
  • Concussion
  • Fertility
  • GERD
  • Kidney Stones
  • Neurofibromatosis
  • Osteo-Arthritis
  • Osteoporosis
  • Trauma (Brain)

Autoimmune

  • Asthma
  • Fibromyalgia
  • Hashimotos
  • Lupus
  • Rheumatoid Arthritis

Cardiovascular

  • Hypertension
  • Hypertrophic Obstructive Cardiomyopathy
  • Plaque Reversal
  • Post-Heart Attack Reperfusion
  • Stent & Bypass Prevention & Support

Central Nervous System

  • Alzheimer’s
  • Dementia
  • Depression
  • Multiple Sclerosis
  • Parkinson’s Disease

Ocular

  • Color Blindness
  • Dry Eyes
  • Epiphora
  • Glaucoma
  • Light Sensitivity
  • Presbyopia
  • Red Eyes
  • Strain
  • Uveitis

Women’s Health

  • Fibrotic Sclerosis
  • Endometriosis
  • Polycystic Ovarian Syndrome

Hemolytics

  • Anemia
  • DVT
  • Post Stroke Intervention
  • Thrombocytopenia

Inflammation

  • Bone/Joint Implant Adjunct Therapy
  • Erythromelalgia
  • Inflammatory Bowel Disease
  • Scleroderma

Metabolic

  • Anorexia
  • Athletic Endurance
  • Cartilage Repair & Maintenance
  • Chronic Fatigue
  • Cushing’s Disease
  • Fatty Acid Liver Disease
  • Hyperlipidemia
  • Hypothyroidism
  • Kawasaki
  • Lipodystrophy
  • Post-Chemo Fatigue
  • Rhabdomyolysis

Oncology

  • Carcinoma Cancer
  • Cancer Immunotherapy
  • Colorectal Cancer
  • Lymphoma
  • Multiple Myeloma
  • NLSC Cancer
  • Ovarian
  • Pancreatic
  • Pre-Treatment
  • Post Treatment

Skin Care

  • Acne
  • Psoriasis
  • Insomnia
  • Sleep Apnea

Circulation

  • Erection & Libido
  • Libido
  • Raynaud’s Disease

Infectious Disease

  • AIDS Support
  • Chronic Mononucleosis
  • Lymes Disease
  • Sepsis

Wounds & Post Trauma

  • Alcohol Poisoning
  • Burn Trauma
  • Decubitus Foot Ulcer 
  • Limb Salvage
  • Osteomyelitis
  • Pressure Ulcers
  • Trauma Wound Closure

Reven’s Research Division continues to qualify, design & prioritize potential therapies throughout each phase of the drug development and commercialization process.

Learn more about RJX products undergoing research.